Your Article Summary
See Latest ArticlesPharma struggles to adapt as patents expire
Corporate News Releases - The Healthcare Sales & Marketing Network, 11/17/08
New threats to drug makers' revenues are rising even as the industry maneuvers to plug huge holes from looming patent expirations. A newly elected U.S. administration under President-elect Barack Obama brings concerns over pricing and further potential scrutiny, at a time when drug companies have already faced increased uncertainty from the regulators of their products.
Today in Regulatory Issues...keeping you current
Receive free subspecialty "5-minute updates" via email
Sixteen Fired for Records Snooping
HealthDataManagement, 12/09/09
Watson Files FDA Application for Generic Rozerem
Watson Pharmaceuticals, 12/07/09
Bristol-Myers Squibb And Pfizer Announce Plans To Submit Regulatory Filing For Apixaban In Europe
Bristol Myers-Squibb Company, 12/07/09